The 4 most recent market catalysts affecting $FME, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 11, 2026
Corporate Catalyst
Neutral
Impact 75
fox e-mobility AG Publishes Audited 2025 Annual Financial Report and Announces Trading Resumption
FOX e-mobility AG's announcement of an audited 2025 net profit and an unconditional auditor's report is a significant positive development, indicating financial stability and trans…
Nov 9, 2026
Corporate Catalyst
Bullish
Impact 55
DZ Bank Raises Price Target for Fresenius Medical Care
DZ Bank's analyst Sven Kürten raised the fair value target for Fresenius Medical Care (FME) from 46 EUR to 50 EUR, while keeping a 'Buy' rating. This positive adjustment stems from…
Nov 5, 2026
Corporate Catalyst
Bearish
Impact 55
Deutsche Bank Research Lowers Price Target for Fresenius Medical Care
Deutsche Bank Research has reduced its price target for Fresenius Medical Care (FME) from 40 to 38 euros, while keeping a 'Hold' rating. This decision stems from the company's thir…
Oct 7, 2026
Corporate Catalyst
Neutral
Impact 75
Fresenius Medical Care Appoints Shervin J. Korangy As CEO Effective October 12; Shervin J. Korangy To Succeed Helen Giza
Fresenius Medical Care (FME) is appointing Shervin J. Korangy as its new CEO, replacing Helen Giza, effective October 12, 2026. This is a significant leadership transition for a ma…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.